Correlation Between Clal Biotechnology and Libra Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Libra Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Libra Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Libra Insurance, you can compare the effects of market volatilities on Clal Biotechnology and Libra Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Libra Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Libra Insurance.

Diversification Opportunities for Clal Biotechnology and Libra Insurance

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Clal and Libra is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Libra Insurance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Libra Insurance and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Libra Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Libra Insurance has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Libra Insurance go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Libra Insurance

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Libra Insurance. But the stock apears to be less risky and, when comparing its historical volatility, Clal Biotechnology Industries is 1.58 times less risky than Libra Insurance. The stock trades about -0.15 of its potential returns per unit of risk. The Libra Insurance is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  73,727  in Libra Insurance on September 4, 2024 and sell it today you would earn a total of  13,563  from holding Libra Insurance or generate 18.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy94.44%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Libra Insurance

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Libra Insurance 

Risk-Adjusted Performance

34 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Libra Insurance are ranked lower than 34 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Libra Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Libra Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Libra Insurance

The main advantage of trading using opposite Clal Biotechnology and Libra Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Libra Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Libra Insurance will offset losses from the drop in Libra Insurance's long position.
The idea behind Clal Biotechnology Industries and Libra Insurance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.